Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown125%
completed250%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

The Olmsted NAFLD Epidemiology Study (TONES)

NCT04365855
completednot_applicable

Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

NCT03612973
unknown

Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.

NCT03241823
completed

Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease

NCT02779946

Clinical Trials (4)

Showing 4 of 4 trials
NCT04365855Not Applicable

The Olmsted NAFLD Epidemiology Study (TONES)

Recruiting
NCT03612973Not Applicable

Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

Completed
NCT03241823

Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.

Unknown
NCT02779946

Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4